Literature DB >> 16228156

[Cardiomyopathies. I: classification of cardiomyopathies--dilated cardiomyopathy].

H P Schultheiss1, M Noutsias, U Kühl, D Lassner, U Gross, W Poller, M Pauschinger.   

Abstract

Cardiomyopathies are common causes of heart failure and sudden cardiac death. According to the WHO classification, "specific" cardiomyopathies are differentiated from "idiopathic" cardiomyopathies. Thus, this classification is primarily based on pathophysiological characteristics. The diagnostic spectrum in cardiomyopathies comprises the entire spectrum of non-invasive and invasive cardiological examination techniques. The exact verification of certain cardiomyopathies necessitates additionally investigations. For example, immunohistological and molecular biological investigations of endomyocardial biopsies may confirm inflammatory cardiomyopathy, which is often induced by viruses. Several studies have shown that specific immunomodulatory treatment options can halt the progressive course of the disease. Several gene mutations have been identified in genetic/familial dilated cardiomyopathy. First-degree relatives should be screened for early stages. Primary prevention of sudden cardiac death shows increasing superiority of the implantable defibrillator compared with pharmacological approaches (i.e. amiodarone).

Entities:  

Mesh:

Year:  2005        PMID: 16228156     DOI: 10.1007/s00108-005-1483-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  78 in total

1.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

2.  Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

3.  Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha.

Authors:  A Heim; I Grumbach; P Pring-Akerblom; M Stille-Siegener; G Müller; R Kandolf; H R Figulla
Journal:  Antiviral Res       Date:  1997-05       Impact factor: 5.970

Review 4.  Thromboembolism in heart failure: who should be treated?

Authors:  F Diet; E Erdmann
Journal:  Eur J Heart Fail       Date:  2000-12       Impact factor: 15.534

5.  Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.

Authors:  K Schulze; B F Becker; R Schauer; H P Schultheiss
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

6.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.

Authors:  H J Why; B T Meany; P J Richardson; E G Olsen; N E Bowles; L Cunningham; C A Freeke; L C Archard
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

7.  Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.

Authors:  Alexander Staudt; Yvonne Staudt; Marcus Dörr; Marco Böhm; Fabian Knebel; Astrid Hummel; Lydia Wunderle; Malte Tiburcy; Klaus D Wernecke; Gert Baumann; Stephan B Felix
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

8.  Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.

Authors:  J G Shanes; J Ghali; M E Billingham; V J Ferrans; J J Fenoglio; W D Edwards; C C Tsai; J E Saffitz; J Isner; S Furner
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

9.  Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy.

Authors:  Michel Noutsias; Matthias Pauschinger; Heinz Schultheiss; Uwe K hl
Journal:  Med Sci Monit       Date:  2002-07

Review 10.  The role of endomyocardial biopsy in the diagnosis of cardiomyopathies.

Authors:  Andrea Frustaci; Maurizio Pieroni; Cristina Chimenti
Journal:  Ital Heart J       Date:  2002-06
View more
  2 in total

1.  [Cardiac magnetic resonance tomography in the diagnostics of restrictive and unclassified cardiopathies].

Authors:  U Kramer; A E May; S Mangold; P Krumm; C D Claussen
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

Review 2.  [State of diagnostics and therapy of inflammatory cardiomyopathie].

Authors:  H P Schultheiss; U Kühl
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.